Aardvark Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AARD Nasdaq 2834 aardvarktherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aardvark Therapeutics, Inc.

Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference - Jun 24th, 2025 6:00 am
Wall Street Analysts Think Aardvark Therapeutics, Inc. (AARD) Could Surge 180.77%: Read This Before Placing a Bet - Jun 3rd, 2025 7:55 am
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions - May 19th, 2025 2:10 pm
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - May 14th, 2025 2:10 pm
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May - May 7th, 2025 2:05 pm
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights - Mar 31st, 2025 2:10 pm
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, But Aardvark Reverses Lower - Mar 27th, 2025 2:18 pm
Aardvark Therapeutics, Inc. Common Stock (AARD): Among Top Insider Purchases Last Month - Mar 14th, 2025 9:25 am
Aardvark Therapeutics (AARD): Among Stocks With At Least $10 Million In Insider Spending Recently - Mar 3rd, 2025 12:55 pm
Aardvark Therapeutics Announces Pricing of Initial Public Offering - Feb 12th, 2025 8:38 pm